Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Drug-DNA recognition: Energetics and implications for design
Haq Ihtshamul
, John Ladbury
Research output
:
Contribution to journal
›
Review article
›
peer-review
136
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug-DNA recognition: Energetics and implications for design'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug Design
100%
DNA Recognition
100%
DNA Drug
100%
Implications for Design
100%
High Sensitivity
50%
DNA Molecule
50%
X-ray Study
50%
Complex Formation
50%
NMR Studies
50%
Thermodynamics
50%
Triplex
50%
Low Molecular Weight Compounds
50%
General Guidelines
50%
High-order
50%
Thermodynamic Study
50%
Structural Details
50%
Biophysical Studies
50%
Binding Energy
50%
Thermodynamic Data
50%
Structure-based Drug Design
50%
Drug Complex
50%
Duplex DNA
50%
Entropic Contribution
50%
Similar Principle
50%
Binding Reaction
50%
Drug-DNA Interaction
50%
Algorithm Design
50%
Tetraplex
50%
Drug Association
50%
Three Dimensional Structure
50%
Structural Thermodynamics
50%
Type of Work
50%
Low-molecular-weight Ligands
50%
Association Reaction
50%
Biochemistry, Genetics and Molecular Biology
Energy Transfer
100%
Thermodynamics
75%
Drug Development
75%
Molecular Weight
25%
Complex Formation
25%
X Ray
25%
DNA Drug Complex
25%
Drug DNA Interaction
25%
Chemistry
Energetics
100%
Deoxyribonucleic Acid
100%
Thermodynamics
42%
Molecular Mass
14%
Base
14%
NMR Spectroscopy
14%
Free Energy
14%
Association Reaction
14%
Complex Formation
14%
Physics
Energetics
100%
Thermodynamics
75%
X Ray
25%
Nuclear Magnetic Resonance
25%
Free Energy
25%
Complex Formation
25%
Low Molecular Weight
25%
Association Reaction
25%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Base
50%
Drug Interaction
50%
Double Stranded DNA
50%
Structure-Based Drug Design
50%